Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

MGCD-0103 receives orphan drug designation for acute myelogenous leukemia

Feb. 12, 2008

VGX Pharmaceuticals files IND for DNA therapy to treat cancer cachexia and anemia

Feb. 11, 2008

Spectrum initiates phase I trial for SPI-1620 as an adjunct to cancer chemotherapy

Feb. 11, 2008

HE-3235 active in hormone-independent prostate cancer models

Feb. 11, 2008

ArQule receives milestone payment from Kyowa Hakko relating to ARQ-197

Feb. 11, 2008

Calibrant enters collaboration with Yale University for ovarian and breast cancer drug targets

Feb. 11, 2008

Insception Biosciences initiates human clinical trials of new stem cell treatment

Feb. 8, 2008

BioNumerik treats first patient in global Karenitecin phase III trial

Feb. 8, 2008

Vermillion and Johns Hopkins agree to co-develop molecular diagnostic tests

Feb. 8, 2008

Renal cancer drug sorafenib inhibits mutant FLT3 in acute myelogenous leukemia

Feb. 8, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...